Australia's largest stock trading and investment forum Australia's #1 stock forum

CDY

Click for more information

1.43%

7.1¢ cellmid limited

Dont see anything regarding general discussion on the agenda...

First 24 Last

Share
Profile

Follow
Pharmargeddon

1,750 Posts.

132

04/09/18

10:30

Post #: 35395913
Share

Originally posted by leverage ↑

Thanks @Pharmargeddon and @mightypirate for your links to Mk related and relevant articles both of which are squarely in the companies area of interest.

Whilst we are eagerly awaiting the outcomes of the ramping up on the Advandgen sales and potentially new distribution agreements, it is disappointing that there "appears" to be less eagerness and energy placed into Lyramid and Kinera. Is it simply a case of keeping the cards close in a competitive Biotech environment or is there a passive "wait to be contacted " approach. Isn't the 4 year CellmidZoetis agreement about to conclude. The CEO previously stated that in the absence of any notification all partnerships remain extant and ongoing. So will we see an announcement in this area in the coming months. What about the QuestLicense update ? Is this test still being developed ?

I trust there may be more detail available at the general meeting this friday.

Expand

Dont see anything regarding general discussion on the agenda unless something comes out during consideration of the proposed resolutions.
Wouldnt hurt to bring it back to their attention if possible though, suggesting that updates could be forthcoming at the AGM.

CDY Price at posting: 38.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

There are more pages in this discussion • 77 more messages in this thread...

First 24 Last

Add CDY (ASX) to my watchlist